KP Tissue Inc
TSX:KPT
KP Tissue Inc
TSX:KPT
Price:
10.74
CAD
0.28%
Market Closed
Market Cap:
CA$107.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
KP Tissue Inc
TSX:KPT
|
CA |
|
Harland & Wolff Group Holdings PLC
LSE:HARL
|
UK |
|
A
|
Allied Machinery Co Ltd
SSE:605060
|
CN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of KPT.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
KPT
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
KPT Competitors Multiples
KP Tissue Inc Competitors
KP Tissue Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
KP Tissue Inc
TSX:KPT
|
107.6m CAD | 0 | 12.6 | 0 | 0 | |
| US |
|
Procter & Gamble Co
NYSE:PG
|
332.6B USD | 3.9 | 20.6 | 14.6 | 16.6 | |
| US |
|
Colgate-Palmolive Co
NYSE:CL
|
68.2B USD | 3.3 | 32 | 14.8 | 16.9 | |
| UK |
|
Reckitt Benckiser Group PLC
LSE:RKT
|
33.8B GBP | 2.4 | 10.6 | 9.6 | 11.7 | |
| US |
|
Kimberly-Clark Corp
NYSE:KMB
|
31.9B USD | 1.9 | 15.8 | 10.8 | 14 | |
| DE |
|
Henkel AG & Co KGaA
XETRA:HEN3
|
26.8B EUR | 1.3 | 12.9 | 6.7 | 8.4 | |
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
22B USD | 3.5 | 29.8 | 16.8 | 20.4 | |
| SE |
|
Essity AB (publ)
STO:ESSITY B
|
167.2B SEK | 1.2 | 13.4 | 7.4 | 10.2 | |
| US |
|
Clorox Co
NYSE:CLX
|
12.2B USD | 1.8 | 16.2 | 11.4 | 13.8 | |
| JP |
|
Unicharm Corp
TSE:8113
|
1.7T JPY | 1.8 | 25.6 | 8.9 | 13 | |
| MX |
|
Kimberly-Clark de Mexico SAB de CV
BMV:KIMBERA
|
127.6B MXN | 2.3 | 16.8 | 9.9 | 11.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
